The bedtime administration ameliorates blood pressure variability and reduces urinary albumin excretion in amlodipine-olmesartan combination therapy

Clinical and Experimental Hypertension

Volumn 32, Issue 7, 2010, Pages 416-422

  Hoshino, Atsushi ^a   Nakamura, Takeshi ^a   Matsubara, Hiroaki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Blood pressure viability; Chronotherapy; Combination therapy; Morning blood pressure surge (MBPS); Urinary albumin excretion

Indexed keywords

ALBUMIN; AMLODIPINE PLUS OLMESARTAN; CREATININE; GLUCOSE; LIPID;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BEDTIME DOSAGE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE VARIABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; CROSSOVER PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ESSENTIAL HYPERTENSION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; LIPID ANALYSIS; MALE; MORNING DOSAGE; RANDOMIZED CONTROLLED TRIAL; URINARY EXCRETION;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINS; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CREATININE; DRUG CHRONOTHERAPY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; IMIDAZOLES; MALE; MIDDLE AGED; TETRAZOLES; TREATMENT OUTCOME;

EID: 78049475264     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641961003667948     Document Type: Article

References (23)

1. White WB. Relating cardiovascular risk to out-of-office blood pressure and the importance of controlling blood pressure 24 hours a day. Am J Med 2008;121(8 suppl):S2-7.
2. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a pro-spective study. Circulation 2003;107:1401-1406.
3. Gosse P, Cipriano C, Bemurat L, Mas D, Lemétayer P, N'Tela G, Clementy J. Prognostic significance of blood pres-sure measured on rising. J Hum Hypertens 2001;15:413-417.
4. Metoki H, Ohkubo T, Kikuya M, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Prognos-tic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension 2006;47:149-154.
5. Kario K, Matsui Y, Shibasaki S, Eguchi K, Ishikawa J, Hoshide S, Ishikawa S, Kabutoya T, Schwartz JE, Pickering TG, Shimada K; Japan Morning Surge-1 (JMS-1) Study Group. An alpha-adrenergic blocker titrated by self-measured blood pres-sure recordings lowered blood pressure and microalbuminuria in patients with morning hypertension: the Japan Morning Surge-1 Study. J Hypertens 2008;26:1257-1265.
6. Kuroda T, Kario K, Hoshide S, Hashimoto T, Nomura Y, Saito Y, Mito H, Shimada K. Effects of bedtime vs. morning administration of the long-acting lipophilic angiotensin-converting enzyme inhibitor trandolapril on morning blood pressure in hypertensive patients. Hypertens Res 2004;27:15-20.
7. Qiu YG, Chen JZ, Zhu JH, Yao XY. Differential effects of morn-ing or evening dosing of amlodipine on circadian blood pressure and heart rate. Cardiovasc Drugs Ther 2003;17:335-341.
8. Kitahara Y, Saito F, Akao M, Fujita H, Takahashi A, Taguchi H, Hino T, Otsuka Y, Kushiro T, Kanmatsuse K. Effect of morning and bedtime dosing with cilnidipine on blood pres-sure, heart rate, and sympathetic nervous activity in essential hypertensive patients. J Cardiovasc Pharmacol 2004;43:68-73.
9. White WB, Mansoor GA, Pickering TG, Vidt DG, Hutchinson HG, Johnson RB, Noveck R. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pres-sure and heart rate. Am J Hypertens 1999;12(8 Pt 1):806-814.
10. Portaluppi F, Vergnani L, Manfredini R, degli Uberti EC, Fersini C. Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. Am J Hypertens 1995;8:719-726.
11. Hermida RC, Ayala DE, Mojón A, Fernández JR. Chrono-therapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing. Am J Hypertens 2008;21:948-954.
12. Hermida RC, Calvo C, Ayala DE, Domínguez MJ, Covelo M, Fernández JR, Mojón A, López JE Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension 2003;42:283-290.
13. Hermida RC, Calvo C, Ayala DE, Mojón A, Rodríguez M, Chayán L, López JE, Fontao MJ, Soler R, Fernández JR. Administration time-dependent effects of valsartan on ambu-latory blood pressure in elderly hypertensive subjects. Chronobiol Int 2005; 22:755-776.
14. Hermida RC, Calvo C, Ayala DE, Fernández JR, Covelo M, Mojón A, López JE. Treatment of non-dipper hypertension with bedtime administration of valsartan. J Hypertens 2005;23:1913-1922.
15. Dahlöf B. Further evidence for low-dose combinations in patients with left ventricular hypertrophy. J Hum Hypertens 2005;19(suppl 1):S9-14.
16. Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ; ACCOMPLISH Trial Investigators. Benazepril plus amlodi-pine or hydrochlo-rothiazide for hypertension in high-risk patients. N Engl J Med 2008;359:2417-2428.
17. Barnett AG, Sans S, Salomaa V, Kuulasmaa K, Dobson AJ; WHO MONICA Project. The effect of temperature on sys-tolic blood pressure. Blood Press Monit 2007; 12:195-203.
18. Takaki A, Ogawa H, Wakeyama T, Iwami T, Kimura M, Hadano Y, Matsuda S, Miyazaki Y, Hiratsuka A, Matsuzaki M. Cardioankle vascular index is superior to brachial-ankle pulse wave velocity as an index of arterial stiffness. Hypertens Res 2008;31:1347-1355.
19. Matchar DB, McCrory DC, Orlando LA, Patel MR, Patel UD, Patwardhan MB, Powers B, Samsa GP, Gray RN. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treat-ing essential hypertension. Ann Intern Med 2008;148: 16-29.
20. Polónia J, Amado P, Barbosa L, Nazaré J, Silva JA, Bertoquini S, Martins L, Carmona J. Morning rise, morning surge and daytime variability of blood pressure and cardiovascular target organ damage. A cross-sectional study in 743 subjects. Rev Port Cardiol 2005;24:65-78.
21. Equiluz-Bruck S, Schnack C, Kopp HP, Schernthaner G. Nondipping of nocturnal blood pressure is related to urinary albumin excretion rate in patients with type 2 diabetes melli-tus. Am J Hypertens 1996;9:1139-1143.
22. Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlöf B, Devereux RB, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wan Y. Reduction in albuminuria translates to reduction in cardio-vascular events in hypertensive patients: losartan interven-tion for endpoint reduction in hypertension study. Hypertension 2005;45: 198-202.
23. Kanbay M, Turgut F, Uyar ME, Akcay A, Covic A. Causes and mechanisms of nondipping hypertension. Clin Exp Hyper-tens. 2008;30:585-597.